EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.1.1.7 | 1-methyl-3-(methylcarbamoyl)-1,4-dihydroquinolin-5-yl dimethylcarbamate | - |
Homo sapiens | |
3.1.1.7 | 1-methyl-3-(morpholin-4-ylcarbonyl)-1,4-dihydroquinolin-5-yl dimethylcarbamate | - |
Homo sapiens | |
3.1.1.7 | 3-(dimethylcarbamoyl)-1-methyl-1,4-dihydroquinolin-5-yl dimethylcarbamate | - |
Homo sapiens | |
3.1.1.7 | 3-(dimethylcarbamoyl)-5-[(dimethylcarbamoyl)oxy]-1-methylquinolinium | - |
Homo sapiens | |
3.1.1.7 | 5-[(dimethylcarbamoyl)oxy]-1-methyl-3-(methylcarbamoyl)quinolinium | - |
Homo sapiens | |
3.1.1.7 | 5-[(dimethylcarbamoyl)oxy]-1-methyl-3-(morpholin-4-ylcarbonyl)quinolinium | - |
Homo sapiens | |
3.1.1.7 | 5-[(dimethylcarbamoyl)oxy]-3-(ethoxycarbonyl)-1-methylquinolinium | - |
Homo sapiens | |
3.1.1.7 | 5-[(dimethylcarbamoyl)oxy]-3-(methoxycarbonyl)-1-methylquinolinium | - |
Homo sapiens | |
3.1.1.7 | 5-[(ethylcarbamoyl)oxy]-3-(methoxycarbonyl)-1-methylquinolinium | - |
Homo sapiens | |
3.1.1.7 | 7-[(dimethylcarbamoyl)oxy]-3-(ethoxycarbonyl)-1-methylquinolinium | - |
Homo sapiens | |
3.1.1.7 | donepezil | - |
Homo sapiens | |
3.1.1.7 | ethyl 5-[(dimethylcarbamoyl)oxy]-1-methyl-1,4-dihydroquinoline-3-carboxylate | - |
Homo sapiens | |
3.1.1.7 | ethyl 7-[(dimethylcarbamoyl)oxy]-1-methyl-1,4-dihydroquinoline-3-carboxylate | - |
Homo sapiens | |
3.1.1.7 | galanthamine | - |
Homo sapiens | |
3.1.1.7 | methyl 5-[(dimethylcarbamoyl)oxy]-1-methyl-1,4-dihydroquinoline-3-carboxylate | - |
Homo sapiens | |
3.1.1.7 | methyl 5-[(ethylcarbamoyl)oxy]-1-methyl-1,4-dihydroquinoline-3-carboxylate | - |
Homo sapiens | |
3.1.1.7 | additional information | synthesis of a set of 1,4-dihydroquinolines and their corresponding quinolinium salts as potential enzyme inhibitors, overview. All reduced forms are unable to exhibit any anticholinesterase activity, while most of the quinolinium salts display high AChE inhibitory activity with IC50 values ranging from 0.006 mM to 7 nM. Design of a bio-oxidisable prodrug for central selective AChE inhibitory activity | Homo sapiens | |
3.1.1.7 | rivastigmine | - |
Homo sapiens |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.1.1.7 | Homo sapiens | - |
- |
- |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
3.1.1.7 | AChE | - |
Homo sapiens |
EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|---|
3.1.1.7 | 0.000007 | - |
- |
Homo sapiens | 5-[(dimethylcarbamoyl)oxy]-3-(ethoxycarbonyl)-1-methylquinolinium | |
3.1.1.7 | 0.000015 | - |
- |
Homo sapiens | 3-(dimethylcarbamoyl)-5-[(dimethylcarbamoyl)oxy]-1-methylquinolinium | |
3.1.1.7 | 0.000029 | - |
- |
Homo sapiens | 5-[(dimethylcarbamoyl)oxy]-1-methyl-3-(methylcarbamoyl)quinolinium | |
3.1.1.7 | 0.00005 | - |
- |
Homo sapiens | donepezil | |
3.1.1.7 | 0.00011 | - |
- |
Homo sapiens | 5-[(dimethylcarbamoyl)oxy]-3-(methoxycarbonyl)-1-methylquinolinium | |
3.1.1.7 | 0.0005 | - |
- |
Homo sapiens | 7-[(dimethylcarbamoyl)oxy]-3-(ethoxycarbonyl)-1-methylquinolinium | |
3.1.1.7 | 0.00086 | - |
- |
Homo sapiens | 5-[(dimethylcarbamoyl)oxy]-1-methyl-3-(morpholin-4-ylcarbonyl)quinolinium | |
3.1.1.7 | 0.006 | - |
- |
Homo sapiens | 5-[(ethylcarbamoyl)oxy]-3-(methoxycarbonyl)-1-methylquinolinium | |
3.1.1.7 | 1 | - |
above | Homo sapiens | methyl 5-[(dimethylcarbamoyl)oxy]-1-methyl-1,4-dihydroquinoline-3-carboxylate | |
3.1.1.7 | 1 | - |
above | Homo sapiens | methyl 5-[(ethylcarbamoyl)oxy]-1-methyl-1,4-dihydroquinoline-3-carboxylate | |
3.1.1.7 | 1 | - |
above | Homo sapiens | ethyl 5-[(dimethylcarbamoyl)oxy]-1-methyl-1,4-dihydroquinoline-3-carboxylate | |
3.1.1.7 | 1 | - |
above | Homo sapiens | ethyl 7-[(dimethylcarbamoyl)oxy]-1-methyl-1,4-dihydroquinoline-3-carboxylate | |
3.1.1.7 | 1 | - |
above | Homo sapiens | 1-methyl-3-(morpholin-4-ylcarbonyl)-1,4-dihydroquinolin-5-yl dimethylcarbamate | |
3.1.1.7 | 1 | - |
above | Homo sapiens | 3-(dimethylcarbamoyl)-1-methyl-1,4-dihydroquinolin-5-yl dimethylcarbamate | |
3.1.1.7 | 1 | - |
above | Homo sapiens | 1-methyl-3-(methylcarbamoyl)-1,4-dihydroquinolin-5-yl dimethylcarbamate |